Randomised, double-blind, placebo-controlled study to assess long-term effect of dupilumab on prevention of lung function decline (LFD) in patients with uncontrolled moderate-to-severe asthma: ATLAS trial

被引：0
|
作者：
Gomez, L. De Prado [1 ]
Pavord, I. [2 ]
Busse, W. [3 ]
Brightling, C. E. [4 ]
Wechsler, M. E. [5 ]
Rabe, K. F. [6 ,7 ,8 ]
Zhang, M. [9 ]
Xing, J. [9 ]
Jacob-Nara, J. A. [9 ]
Rowe, P. J. [9 ]
机构：
[1] Sanofi, Reading, Berks, England
[2] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[3] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Sch Med & Publ Hlth, Madison, WI USA
[4] Univ Leicester, Inst Lung Hlth, Dept Resp Sci, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
[5] Natl Jewish Hlth, Denver, CO USA
[6] LungenClin Grosshansdorf, Grosshansdorf, Germany
[7] German Ctr Lung Res DZL, ARCN, Grosshansdorf, Germany
[8] Univ Kiel, ARCN, German Ctr Lung Res DZL, Kiel, Germany
[9] Sanofi, Bridgewater, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2288
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2288
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
    Gomez, Lucia De Prado
    Pavord, Ian
    Busse, William
    Brightling, Christopher E.
    Wechsler, Michael E.
    Rabe, Klaus F.
    Zhang, Mei
    Xing, Jun
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [2] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECT OF DUPILUMAB ON AIRWAY REMODELING IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: THE VESTIGE STUDY
    Gomez, Lucia De Prado
    Castro, Mario
    Papi, Alberto
    Ardeleanu, Marius
    Deniz, Yamo
    Rowe, Paul
    CHEST, 2021, 160 (04) : 1492A - 1495A
  • [3] Effects of Dupilumab on Mucus Plugging and Ventilation Defects in Patients with Moderate-to-Severe Asthma: A Randomized, Double-Blind, Placebo-Controlled Trial
    Svenningsen, Sarah
    Kjarsgaard, Melanie
    Haider, Ehsan
    Venegas, Carmen
    Konyer, Norman
    Friedlander, Yonni
    Nasir, Neha
    Boylan, Colm
    Kirby, Miranda
    Nair, Parameswaran
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (09) : 995 - 997
  • [4] Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
    Diver, Sarah
    Khalfaoui, Latifa
    Emson, Claire
    Wenzel, Sally E.
    Menzies-Gow, Andrew
    Wechsler, Michael E.
    Johnston, James
    Molfino, Nestor
    Parnes, Jane R.
    Megally, Ayman
    Colice, Gene
    Brightling, Christopher E.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : 1299 - 1312
  • [5] Effect of Tezepelumab on Airway Inflammation in Patients with Moderate-to-Severe Uncontrolled Asthma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study (CASCADE)
    Diver, S. E.
    Khalfaoui, L.
    Emson, C.
    Wenzel, S. E.
    Menzies-Gow, A.
    Wechsler, M.
    Johnston, J.
    Downie, J.
    Parnes, J. R.
    Megally, A.
    Colice, G.
    Brightling, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [7] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
    Danese, Silvio
    Rudzinski, Janusz
    Brandt, Wolfgang
    Dupas, Jean-Louis
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Kleczkowski, Dariusz
    Uebel, Peter
    Lukas, Milan
    Knutsson, Mikael
    Erlandsson, Fredrik
    Hansen, Mark Berner
    Keshav, Satish
    GUT, 2015, 64 (02) : 243 - 249
  • [9] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Busse, William W.
    Maspero, Jorge F.
    Rabe, Klaus F.
    Papi, Alberto
    Wenzel, Sally E.
    Ford, Linda B.
    Pavord, Ian D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Pirozzi, Gianluca
    Amin, Nikhil
    Akinlade, Bolanle
    Eckert, Laurent
    Chao, Jingdong
    Graham, Neil M. H.
    Teper, Ariel
    ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
  • [10] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    William W. Busse
    Jorge F. Maspero
    Klaus F. Rabe
    Alberto Papi
    Sally E. Wenzel
    Linda B. Ford
    Ian D. Pavord
    Bingzhi Zhang
    Heribert Staudinger
    Gianluca Pirozzi
    Nikhil Amin
    Bolanle Akinlade
    Laurent Eckert
    Jingdong Chao
    Neil M. H. Graham
    Ariel Teper
    Advances in Therapy, 2018, 35 : 737 - 748
12345